Guofen Yan1, Jenny I Shen2,3, Rubette Harford4,5, Wei Yu6, Robert Nee7, Mary Jo Clark8, Jose Flaque5, Jose Colon5, Francisco Torre5, Ylene Rodriguez5, Jane Georges8, Lawrence Agodoa9, Keith C Norris10. 1. Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia; guofen.yan@virginia.edu knorris@ucla.edu. 2. Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California. 3. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California. 4. School of Nursing, Mount St. Mary's University, Los Angeles, California. 5. Atlantis Healthcare Group-Puerto Rico, Trujillo Alto, Puerto Rico. 6. Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia. 7. Department of Nephrology, Walter Reed National Military Medical Center, Uniformed Services University, Bethesda, Maryland. 8. Hahn School of Nursing and Health Science, University of San Diego, San Diego, California; and. 9. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 10. Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; guofen.yan@virginia.edu knorris@ucla.edu.
Abstract
BACKGROUND AND OBJECTIVES: In the United States mortality rates for patients treated with dialysis differ by racial and/or ethnic (racial/ethnic) group. Mortality outcomes for patients undergoing maintenance dialysis in the United States territories may differ from patients in the United States 50 states. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study of using US Renal Data System data included 1,547,438 adults with no prior transplantation and first dialysis treatment between April 1, 1995 and September 28, 2012. Cox proportional hazards regression was used to calculate hazard ratios (HRs) of death for the territories versus 50 states for each racial/ethnic group using the whole cohort and covariate-matched samples. Covariates included demographics, year of dialysis initiation, cause of kidney failure, comorbid conditions, dialysis modality, and many others. RESULTS: Of 22,828 patients treated in the territories (American Samoa, Guam, Puerto Rico, Virgin Islands), 321 were white, 666 were black, 20,299 were Hispanic, and 1542 were Asian. Of 1,524,610 patients in the 50 states, 838,736 were white, 444,066 were black, 182,994 were Hispanic, and 58,814 were Asian. The crude mortality rate (deaths per 100 patient-years) was lower for whites in the territories than the 50 states (14 and 29, respectively), similar for blacks (18 and 17, respectively), higher for Hispanics (27 and 16, respectively), and higher for Asians (22 and 15). In matched analyses, greater risks of death remained for Hispanics (HR, 1.65; 95% confidence interval, 1.60 to 1.70; P<0.001) and Asians (HR, 2.01; 95% confidence interval, 1.78 to 2.27; P<0.001) living in the territories versus their matched 50 states counterparts. There were no significant differences in mortality among white or black patients in the territories versus the 50 states. CONCLUSIONS: Mortality rates for patients undergoing dialysis in the United States territories differ substantially by race/ethnicity compared with the 50 states. After matched analyses for comparable age and risk factors, mortality risk no longer differed for whites or blacks, but remained much greater for territory-dwelling Hispanics and Asians.
BACKGROUND AND OBJECTIVES: In the United States mortality rates for patients treated with dialysis differ by racial and/or ethnic (racial/ethnic) group. Mortality outcomes for patients undergoing maintenance dialysis in the United States territories may differ from patients in the United States 50 states. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study of using US Renal Data System data included 1,547,438 adults with no prior transplantation and first dialysis treatment between April 1, 1995 and September 28, 2012. Cox proportional hazards regression was used to calculate hazard ratios (HRs) of death for the territories versus 50 states for each racial/ethnic group using the whole cohort and covariate-matched samples. Covariates included demographics, year of dialysis initiation, cause of kidney failure, comorbid conditions, dialysis modality, and many others. RESULTS: Of 22,828 patients treated in the territories (American Samoa, Guam, Puerto Rico, Virgin Islands), 321 were white, 666 were black, 20,299 were Hispanic, and 1542 were Asian. Of 1,524,610 patients in the 50 states, 838,736 were white, 444,066 were black, 182,994 were Hispanic, and 58,814 were Asian. The crude mortality rate (deaths per 100 patient-years) was lower for whites in the territories than the 50 states (14 and 29, respectively), similar for blacks (18 and 17, respectively), higher for Hispanics (27 and 16, respectively), and higher for Asians (22 and 15). In matched analyses, greater risks of death remained for Hispanics (HR, 1.65; 95% confidence interval, 1.60 to 1.70; P<0.001) and Asians (HR, 2.01; 95% confidence interval, 1.78 to 2.27; P<0.001) living in the territories versus their matched 50 states counterparts. There were no significant differences in mortality among white or black patients in the territories versus the 50 states. CONCLUSIONS: Mortality rates for patients undergoing dialysis in the United States territories differ substantially by race/ethnicity compared with the 50 states. After matched analyses for comparable age and risk factors, mortality risk no longer differed for whites or blacks, but remained much greater for territory-dwelling Hispanics and Asians.
Authors: Mahiben Maruthappu; Joseph Shalhoub; Zoon Tariq; Callum Williams; Rifat Atun; Alun H Davies; Thomas Zeltner Journal: Int J Stroke Date: 2015-01-15 Impact factor: 5.266
Authors: Daniel Murphy; Charles E McCulloch; Feng Lin; Tanushree Banerjee; Jennifer L Bragg-Gresham; Mark S Eberhardt; Hal Morgenstern; Meda E Pavkov; Rajiv Saran; Neil R Powe; Chi-Yuan Hsu Journal: Ann Intern Med Date: 2016-08-02 Impact factor: 25.391
Authors: J S Wong; F K Port; T E Hulbert-Shearon; C E Carroll; R A Wolfe; L Y Agodoa; J T Daugirdas Journal: Kidney Int Date: 1999-06 Impact factor: 10.612
Authors: Lauren M Kucirka; Morgan E Grams; Justin Lessler; Erin Carlyle Hall; Nathan James; Allan B Massie; Robert A Montgomery; Dorry L Segev Journal: JAMA Date: 2011-08-10 Impact factor: 56.272
Authors: Ryan L Minster; Nicola L Hawley; Chi-Ting Su; Guangyun Sun; Erin E Kershaw; Hong Cheng; Olive D Buhule; Jerome Lin; Muagututi'a Sefuiva Reupena; Satupa'itea Viali; John Tuitele; Take Naseri; Zsolt Urban; Ranjan Deka; Daniel E Weeks; Stephen T McGarvey Journal: Nat Genet Date: 2016-07-25 Impact factor: 38.330
Authors: Ana C Ricardo; Michael F Flessner; John H Eckfeldt; Paul W Eggers; Nora Franceschini; Alan S Go; Nathan M Gotman; Holly J Kramer; John W Kusek; Laura R Loehr; Michal L Melamed; Carmen A Peralta; Leopoldo Raij; Sylvia E Rosas; Gregory A Talavera; James P Lash Journal: Clin J Am Soc Nephrol Date: 2015-09-28 Impact factor: 8.237